▲ Up
 
14:52 23-05-2017
MAIN АКИpress CA-News
ADVERTISE WITH US SUBSCRIBE
KazakhstanKyrgyzstanMongoliaTajikistanTurkmenistanUzbekistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug to crack resistant TB
13:01, 25 March 2014, 1474

AKIPRESS.COM - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.


Full access to all news articles in English

1 month2000 somsubscribe
year20000 somsubscribe
These subscription fees are for private individuals only. Please contact us via phone +996 (312) 900-776 or email info@akipress.org for corporate subscription inquiries
Twitterfacebookprint
LATEST NEWS
14:47 Legislators propose to reprimand Parliament Speaker for failure to publish draft changes to law on presidential and parliament elections14:30 Kyrgyzstan joins GÉANT pan-European network connecting 36 countries14:20 About 3,000 people left jobless after fire burned market to ground in Uzbekistan14:03 Delegation of Issyk-Kul visits Osh14:03 Government discusses ongoing spring sowing campaign13:03 Issyk-Kul residents opposing to transfering of 25 ha of land to Khan-Tengri Nature Park12:52 Mongolian language database developed12:49 No Kazakhstanis hurt in Ariana Grande concert blast: MFA12:44 Kyrgyz Consul General, Guangzhou Chamber of Commerce discuss ties12:42 EU to support pension reform in Tajikistan until 202012:31 Tajik teachers suggest to create organization of followers of Leader of Nation12:24 Incumbent prime ministers must step down as soon as they announce their intention to run for president: MP12:20 South Korea's ex-leader Park abused power to gain bribes, prosecutor tells court12:04 Kyrgyzstan seeks to down wheat yields, up cotton and sugar beet output in 201711:58 200 mln som spent for development of border areas with special status in Kyrgyzstan annually11:54 Russia wants to buy 50% of kidney beans produced in Kyrgyzstan11:37 Rising water washes out bridge on Chatkal River in Jalal-Abad11:19 Ramadan 2017 to begin on May 27 in Kyrgyzstan11:19 North Korea says missile ready for mass production, U.S. questions progress11:13 Russia, Kazakhstan to cooperate on development of medium-class rocket
© AKIpress News Agency - 2001-2017. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75